Longitudinal patterns of chemotherapy use in metastatic colorectal cancer.
Multiple agents and combination therapies available to patients with advanced colorectal cancer have significantly improved survival and provided an opportunity for individualization of care, allowing clinicians and patients to prioritize risks and benefits of comparable regimens.
Zafar
S Yousuf
SY
Cancer Center Biostatistics; Division of Medical Oncology, Department of Medicine; and Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC.
Marcello
Jennifer E
JE
Wheeler
Jane L
JL
Rowe
Krista L
KL
Morse
Michael A
MA
Herndon
James E
JE
Abernethy
Amy P
AP